NLRP3 and Menkes disease: Critically, emerging immunophenotyping classifies MD into: autoinflammatory (13%, NLRP3 inflammasome activation, elevated IL-1β), autoimmune (20%, high TNF-α), allergic (25%, type 2 cytokines, IgE), and low cytokine levels (42%) (26).